NCT01005472 2020-08-03Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaJonsson Comprehensive Cancer CenterPhase 1 Completed16 enrolled
NCT00890747 2014-03-17Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyNational Cancer Institute (NCI)Phase 1 Completed42 enrolled